Data protection Impressum

Newsroom

Researchers from EPFL’s Neuchâtel-based PV Lab and CSEM have achieved a certified 30% power conversion efficiency for a triple-junction solar cell, setting a new world record and opening the door to affordable next-generation photovoltaics for terrestrial and space applications.

EPFL and CSEM set world record for triple-junction solar cell efficiency

18 March 2026

The canton of Fribourg hosted the international BIOKET conference for the first time in Switzerland from 17-19 March 2026, a milestone that reflects its growing standing as one of Europe's most dynamic bioeconomy ecosystems.

The canton of Fribourg makes its mark at BIOKET 2026

18 March 2026

Mondelēz International inaugurates new Toblerone production line in Bern

17 March 2026

Fribourg-based legal tech company Neur.on is integrating its eight-member natural language processing team into European legal AI scale-up Noxtua, while continuing to develop its own AI translation platform for the legal and financial sectors.

Neur.on’s NLP team joins European legal AI scale-up Noxtua

16 March 2026

The Swiss Data Science Center has officially inaugurated its new headquarters at Biopôle in Lausanne, marking its first independent home outside its founding institutions EPFL and ETH Zurich.

The Swiss Data Science Center inaugurates its headquarters at Biopôle in Lausanne

16 March 2026

Seprify has raised CHF 12.25 million in Series A funding to transition its cellulose platform from pilot validation into industrial-scale supply across cosmetics, food, and coatings markets.

Seprify raises CHF 12.25 million to scale its cellulose-based materials platform

11 March 2026

HeroSupport, a spin-off from the University Hospitals of Geneva, has obtained CE Mark certification for VENUS SHELL, a personalized 3D-printed breast immobilization system for prone radiotherapy.

HeroSupport receives CE Mark for its VENUS SHELL radiotherapy device

10 March 2026

Lausanne-based Polares Medical has closed an oversubscribed USD 50 million Series C financing round to advance clinical studies of its MRace Posterior Leaflet Replacement system for mitral regurgitation across the US, Europe, and Australia.

Polares Medical raises USD 50 million to advance its mitral valve replacement system

9 March 2026

Alithea Genomics has completed its seed financing round with an additional CHF 3 million, bringing the total to CHF 6.9 million, to accelerate the commercialization of its large-scale RNA sequencing platforms for drug screening and toxicology.

Alithea Genomics raises CHF 6.9 million to industrialize RNA sequencing

9 March 2026

Geneva's University Hospitals (HUG) are launching a dedicated Women's Cardiovascular Health Center to address the underdiagnosis of heart disease in women.

Geneva’s HUG launches a dedicated cardiovascular health center for women

9 March 2026

1 … 4 5 6 7 8 9 10 11 12 … 91